{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:55:54Z","timestamp":1792464954258,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jmii.2022.08.017","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T11:49:58Z","timestamp":1664365798000},"page":"337-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Correlation between antibiotic consumption and resistance of Pseudomonas aeruginosa in a teaching hospital implementing an antimicrobial stewardship program: A longitudinal observational study"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0444-0877","authenticated-orcid":false,"given":"Hsiao-Wen","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1660-0436","authenticated-orcid":false,"given":"Hsin-Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Chuan","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi-Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Er-Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Hsin","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Ying","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuarn-Jang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2022.08.017_bib1","series-title":"Report on the burden of endemic health care\u2013associated infection worldwide","author":"Allegranzi","year":"2011"},{"issue":"1","key":"10.1016\/j.jmii.2022.08.017_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/ice.2019.296","article-title":"Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: summary of data reported to the National Healthcare Safety Network, 2015-2017","volume":"41","author":"Weiner-Lastinger","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"10.1016\/j.jmii.2022.08.017_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! an update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2022.08.017_bib4","series-title":"Antibiotic resistance threats in the United States, 2019","year":"2019"},{"key":"10.1016\/j.jmii.2022.08.017_bib5","series-title":"Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics","author":"World Health Organization","year":"2017"},{"issue":"10325","key":"10.1016\/j.jmii.2022.08.017_bib6","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jmii.2022.08.017_bib7","series-title":"The resistance phenomenon in microbes and infectious disease vectors: implications for human health and strategies for containment: workshop summary","author":"Knobler","year":"2003"},{"issue":"6","key":"10.1016\/j.jmii.2022.08.017_bib8","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/jac\/dkr103","article-title":"Correlation between antibiotic consumption and resistance of Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009","volume":"66","author":"Lai","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.jmii.2022.08.017_bib9","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2022.08.017_bib10","series-title":"Document M100-S27","article-title":"Performance standards for antimicrobial susceptibility testing","year":"2017"},{"issue":"6 Pt 2","key":"10.1016\/j.jmii.2022.08.017_bib11","first-page":"71S","article-title":"The role of the fluoroquinolones","volume":"12","author":"Guay","year":"1992","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.jmii.2022.08.017_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0732-8893(01)00287-5","article-title":"Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): more alike than different","volume":"41","author":"Jones","year":"2001","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.jmii.2022.08.017_bib13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.amjmed.2004.09.015","article-title":"Fluoroquinolone prescribing in the United States: 1995 to 2002","volume":"118","author":"Linder","year":"2005","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.jmii.2022.08.017_bib14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13756-020-00793-8","article-title":"Development of in\u00a0vitro resistance to fluoroquinolones in Pseudomonas aeruginosa","volume":"9","author":"Zhao","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.jmii.2022.08.017_bib15","series-title":"CLSI rationale document MR02","article-title":"Fluoroquinolone breakpoints for enterbacteriaceae and Pseudomonas aeruginosa","year":"2019"},{"issue":"19","key":"10.1016\/j.jmii.2022.08.017_bib16","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1093\/ajhp\/60.19.1962","article-title":"Effect of fluoroquinolone expenditures on susceptibility of Pseudomonas aeruginosa to ciprofloxacin in U.S. hospitals","volume":"60","author":"Bhavnani","year":"2003","journal-title":"Am J Health Syst Pharm"},{"issue":"4","key":"10.1016\/j.jmii.2022.08.017_bib17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1086\/422647","article-title":"Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities","volume":"39","author":"Polk","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jmii.2022.08.017_bib18","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijantimicag.2004.06.002","article-title":"Associations between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a private, university-affiliated teaching hospital: an 8-year-experience: 1995-2002","volume":"24","author":"Mohr","year":"2004","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.jmii.2022.08.017_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jac\/dkg269","article-title":"The mutant selection window and antimicrobial resistance","volume":"52","author":"Drlica","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.jmii.2022.08.017_bib20","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1086\/511642","article-title":"Mutant selection window hypothesis updated","volume":"44","author":"Drlica","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jmii.2022.08.017_bib21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijantimicag.2005.10.005","article-title":"Mutant prevention concentration for ciprofloxacin and levofloxacin with Pseudomonas aeruginosa","volume":"27","author":"Hansen","year":"2006","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.jmii.2022.08.017_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijantimicag.2009.11.007","article-title":"Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but not ciprofloxacin use","volume":"35","author":"Lee","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl 5","key":"10.1016\/j.jmii.2022.08.017_bib23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1469-0691.2005.01238.x","article-title":"Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance","volume":"11","author":"Peterson","year":"2005","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"10.1016\/j.jmii.2022.08.017_bib24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ajic.2003.09.002","article-title":"National nosocomial infections surveillance (NNIS) system report, data summary from January 1992 through June 2003, issued August 2003","volume":"31","year":"2003","journal-title":"Am J Infect Control"},{"issue":"1","key":"10.1016\/j.jmii.2022.08.017_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5144\/0256-4947.2016.23","article-title":"Antimicrobial resistance patterns of Pseudomonas aeruginosa in tertiary care hospitals of Makkah and Jeddah","volume":"36","author":"Khan","year":"2016","journal-title":"Ann Saudi Med"},{"issue":"3","key":"10.1016\/j.jmii.2022.08.017_bib26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4103\/0974-777X.68531","article-title":"Extended-spectrum \u03b2-lactamases in gram negative bacteria","volume":"2","author":"Rawat","year":"2010","journal-title":"J Global Infect Dis"},{"issue":"Suppl 4","key":"10.1016\/j.jmii.2022.08.017_bib27","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1086\/382690","article-title":"Collateral damage\" from cephalosporin or quinolone antibiotic therapy","volume":"38","author":"Paterson","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jmii.2022.08.017_bib28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/510590","article-title":"Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy","volume":"44","author":"Lodise","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2022.08.017_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijid.2020.06.022","article-title":"Comparison of extended versus intermittent infusion of antipseudomonal beta-lactams for the treatment of critically ill patients with respiratory infections: a systematic review and meta-analysis","volume":"98","author":"Aboulatta","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.jmii.2022.08.017_bib30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1473-3099(17)30615-1","article-title":"Prolonged versus short-term intravenous infusion of antipseudomonal \u03b2-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials","volume":"18","author":"Vardakas","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.jmii.2022.08.017_bib31","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1186\/s12879-020-05149-6","article-title":"Comparing clinical outcomes of piperacillin-tazobactam administration and dosage strategies in critically ill adult patients: a systematic review and meta-analysis","volume":"20","author":"Fawaz","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"11","key":"10.1016\/j.jmii.2022.08.017_bib32","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3390\/antibiotics10111311","article-title":"Assessment of a PK\/PD target of continuous infusion beta-lactams useful for preventing microbiological failure and\/or resistance development in critically ill patients Affected by documented gram-negative infections","volume":"10","author":"Gatti","year":"2021","journal-title":"Antibiotics"},{"issue":"3","key":"10.1016\/j.jmii.2022.08.017_bib33","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijantimicag.2019.06.009","article-title":"Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018","volume":"54","author":"Lee","year":"2019","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.jmii.2022.08.017_bib34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3949\/ccjm.80a.12182","article-title":"Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients","volume":"80","author":"Perez","year":"2013","journal-title":"Cleve Clin J Med"},{"issue":"5","key":"10.1016\/j.jmii.2022.08.017_bib35","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/antibiotics10050586","article-title":"Impact of an antimicrobial stewardship program on the incidence of carbapenem resistant gram-negative Bacilli: an interrupted time-series analysis","volume":"10","author":"L\u00f3pez-Vi\u00f1au","year":"2021","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.jmii.2022.08.017_bib36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jmii.2014.01.005","article-title":"Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: prevalence, risk factors, and impact on outcome of infections","volume":"49","author":"Lin","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"issue":"3","key":"10.1016\/j.jmii.2022.08.017_bib37","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jmii.2021.07.015","article-title":"Multicenter surveillance of antimicrobial susceptibilities and resistance mechanisms among Enterobacterales species and non-fermenting Gram-negative bacteria from different infection sources in Taiwan from 2016 to 2018","volume":"55","author":"Jean","year":"2022","journal-title":"J Microbiol Immunol Infect"},{"issue":"6","key":"10.1016\/j.jmii.2022.08.017_bib38","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ajic.2018.10.025","article-title":"The impact of carbapenem-resistant Pseudomonas aeruginosa on clinical and economic outcomes in a Chinese tertiary care hospital: a propensity score-matched analysis","volume":"47","author":"Chen","year":"2019","journal-title":"Am J Infect Control"},{"issue":"3","key":"10.1016\/j.jmii.2022.08.017_bib39","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jmii.2017.08.015","article-title":"Risk factors for healthcare-associated infection caused by carbapenem-resistant Pseudomonas aeruginosa","volume":"51","author":"Tsao","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"issue":"12","key":"10.1016\/j.jmii.2022.08.017_bib40","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1086\/340532","article-title":"Looking for risk factors for the acquisition of antibiotic resistance: a 21st-century approach","volume":"34","author":"Paterson","year":"2002","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118222001463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118222001463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:28:14Z","timestamp":1761658094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118222001463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1684118222001463"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2022.08.017","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between antibiotic consumption and resistance of Pseudomonas aeruginosa in a teaching hospital implementing an antimicrobial stewardship program: A longitudinal observational study","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2022.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}